Angola vs South Africa: Incidence of tuberculosis
Incidence of tuberculosis over time
- Angola
- South Africa
How they compare
South Africa currently reports 389 per 100,000 people against 373 per 100,000 people in Angola, a difference of 16 per 100,000 people.
Across all 25 years both countries report, South Africa has been ahead every year.
Angola ranks 15th and South Africa ranks 12th of 208 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 439.3 per 100,000 people | 1,108 per 100,000 people | 668.7 per 100,000 people | South Africa |
| 2010s | 440 per 100,000 people | 959.3 per 100,000 people | 519.3 per 100,000 people | South Africa |
| 2020s | 375.8 per 100,000 people | 471.8 per 100,000 people | 96 per 100,000 people | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Angola or South Africa?
- South Africa, at 389 per 100,000 people against 373 per 100,000 people in Angola as of 2024.
- What is the difference in incidence of tuberculosis between Angola and South Africa?
- 16 per 100,000 people, with South Africa ahead.
- How many years of comparable data are there for Angola and South Africa?
- 25 years are reported by both, from 2000 to 2024.
- How do Angola and South Africa rank globally for incidence of tuberculosis?
- Angola ranks 15th and South Africa ranks 12th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.